Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: Potential role of moxifloxacin
- 1 October 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 33 (10) , 1790-1800
- https://doi.org/10.1016/j.jcrs.2007.06.026
Abstract
To aid the cataract surgeon's understanding of rational approaches to antimicrobial prophylaxis and place the European Society of Cataract & Refractive Surgeons (ESCRS) postoperative endophthalmitis study in perspective, a review was conducted of published and unpublished data on intracameral antibiotic use during cataract surgery and the antimicrobial efficacy, pharmacodynamics, ocular penetration, and safety of moxifloxacin. The ESCRS-sponsored study of postoperative endophthalmitis prophylaxis reported rates of presumed infectious postoperative endophthalmitis of 0.07% with intracameral cefuroxime treatment and 0.34% in control groups. Postoperative endophthalmitis after cefuroxime use was mostly due to cefuroxime-resistant gram-positive bacteria. Intracameral cefuroxime also requires extemporaneous compounding, has short-term stability, and carries a risk for hypersensitivity. Moxifloxacin, a fourth-generation fluoroquinolone, has potent and rapid bactericidal activity against the most common gram-positive postoperative endophthalmitis pathogens, has excellent ocular penetration after topical administration, and is available in a self-preserved ophthalmic formulation that has been shown safe and effective in preventing endophthalmitis when administered intracamerally in an animal model. Available data suggest that the optimum antibiotic regimen and route of delivery for cataract surgery antimicrobial prophylaxis require further study. Moxifloxacin offers many theoretical advantages that make it an attractive first-line choice for topical use and of interest for intracameral administration.Keywords
This publication has 57 references indexed in Scilit:
- Comparative In Vitro Activity of Ceftobiprole against Staphylococci Displaying Normal and Small-Colony Variant PhenotypesAntimicrobial Agents and Chemotherapy, 2005
- The Effect of Fourth-Generation Fluoroquinolones Gatifloxacin and Moxifloxacin on Epithelial Healing Following Photorefractive KeratectomyAmerican Journal of Ophthalmology, 2005
- Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humorOphthalmology, 2005
- Severe anaphylactic reaction after intracameral antibiotic administration during cataract surgeryJournal of Cataract & Refractive Surgery, 2005
- A Clone of Methicillin-ResistantStaphylococcus aureusamong Professional Football PlayersNew England Journal of Medicine, 2005
- Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit modelAmerican Journal of Ophthalmology, 2004
- Practice styles and preferences of ASCRS members—2002 surveyJournal of Cataract & Refractive Surgery, 2003
- Bacterial endophthalmitis after small-incision cataract surgeryJournal of Cataract & Refractive Surgery, 2003
- Nosocomial acute-onset postoperative endophthalmitis surveyOphthalmology, 1998
- Geographic Variation in Utilization of Cataract SurgeryMedical Care, 1995